SEC Form 4 · accession 0001437749-15-002317
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Natalie C. Holles
Officer — SVP, Business Development
Period of report
Feb 9, 2015
Accepted (ET)
Feb 10, 2015 · 9:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 9, 2015 | A | 14,000 | $0.00 | A | 18,452 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $25.97 | Feb 9, 2015 | A | 24,000 | A | — | Dec 31, 2024 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a right to receive one share of Hyperion Therapeutics, Inc. common stock, subject to continued service.
- F2One-fourth of the total restricted stock units vest annually beginning January 1, 2016.
- F3One-fourth of the shares underlying the option will vest and become exercisable beginning January 1, 2016, and the remaining three-fourths of the shares will vest monthly over the three years thereafter, subject to continued service.